Alabama state pandemic guidance advises denying ventilators for use by people with metastatic cancer, AIDS and end-stage liver disease.

Instead of non-alcoholic fatty liver disease, they suggest calling it metabolic-associated fatty liver disease.

Gilead Sciences’ direct-acting antiviral regimen was previously approved for adults.

Just under 1% of pregnant women in the state overall up to 2% in central and western New York have hep C antibodies.

Six weeks, compared with the standard 12 weeks, was associated with an unacceptably high rate of viral relapse.

A recent analysis found that health care providers missed opportunities to test 90% of such patients.

Researchers believe this finding may have implications for human health.

Non-alcoholic steatohepatitis, the more severe form of non-alcoholic fatty liver disease, is highly prevalent in the HIV population.

A recent study found that providing opioid use disorder treatment was associated with a high hep C cure rate and less drug use.

Though low, this figure is three times the rate of discontinuation seen in clinical trials.